> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Peanut Allergy Therapy
- URL: https://www.fdaweb.com/panel-to-review-peanut-allergy-therapy/
- Published: 2020-02-24T12:00:00.000Z
- Updated: 2026-09-14T16:04:13.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146155

*Federal Register* notice: FDA has announced a 5/15 Allergenic Products Advisory Committee meeting. Panel members are scheduled to discuss and make recommendations on the safety and efficacy of DBV Technologies’ Peanut (Arachis hypogaea) Allergen Extract for treating patients aged four to 11 years old with a confirmed diagnosis of peanut allergy. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-02-24/pdf/2020-03604.pdf?ref=fdaweb.com).